• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

少突胶质细胞瘤的分子遗传学方面,包括通过比较基因组杂交进行分析。

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

作者信息

Bigner S H, Matthews M R, Rasheed B K, Wiltshire R N, Friedman H S, Friedman A H, Stenzel T T, Dawes D M, McLendon R E, Bigner D D

机构信息

Departments of Pathology, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Am J Pathol. 1999 Aug;155(2):375-86. doi: 10.1016/S0002-9440(10)65134-6.

DOI:10.1016/S0002-9440(10)65134-6
PMID:10433931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1866844/
Abstract

Oligodendroglial neoplasms are a subgroup of gliomas with distinctive morphological characteristics. In the present study we have evaluated a series of these tumors to define their molecular profiles and to determine whether there is a relationship between molecular genetic parameters and histological pattern in this tumor type. Loss of heterozygosity (LOH) for 1p and 19q was seen in 17/23 (74%) well-differentiated oligodendrogliomas, in 18/23 (83%) anaplastic oligodendrogliomas, and in 3/8 (38%) oligoastrocytomas grades II and III. LOH for 17p and/or mutations of the TP53 gene occurred in 14 of these 55 tumors. Only one of the 14 cases with 17p LOH/TP53 gene mutation also had LOH for 1p and 19q, and significant astrocytic elements were seen histologically in the majority of these 14 tumors. LOH for 9p and/or deletion of the CDKN2A gene occurred in 15 of these 55 tumors, and 11 of these cases were among the 24 (42%) anaplastic oligodendrogliomas. Comparative genomic hybridization (CGH) identified the majority of cases with 1p and 19q loss and, in addition, showed frequent loss of chromosomes 4, 14, 15, and 18. These findings demonstrate that oligodendroglial neoplasms usually have loss of 1p and 19q whereas astrocytomas of the progressive type frequently contain mutations of the TP53 gene, and that 9p loss and CDKN2A deletions are associated with progression from well-differentiated to anaplastic oligodendrogliomas.

摘要

少突胶质细胞瘤是具有独特形态特征的胶质瘤亚群。在本研究中,我们评估了一系列此类肿瘤,以确定其分子谱,并确定该肿瘤类型中分子遗传参数与组织学模式之间是否存在关联。在23例分化良好的少突胶质细胞瘤中有17例(74%)出现1p和19q杂合性缺失(LOH),23例间变性少突胶质细胞瘤中有18例(83%)出现,8例II级和III级少突星形细胞瘤中有3例(38%)出现。在这55例肿瘤中,有14例出现17p LOH和/或TP53基因突变。在14例17p LOH/TP53基因突变的病例中,只有1例同时出现1p和19q LOH,并且在这14例肿瘤中的大多数在组织学上可见明显的星形细胞成分。在这55例肿瘤中,有15例出现9p LOH和/或CDKN2A基因缺失,其中11例在24例(42%)间变性少突胶质细胞瘤中。比较基因组杂交(CGH)确定了大多数1p和19q缺失的病例,此外,还显示出4号、14号、15号和18号染色体频繁缺失。这些发现表明,少突胶质细胞瘤通常有1p和19q缺失,而进展型星形细胞瘤经常含有TP53基因突变,并且9p缺失和CDKN2A基因缺失与从分化良好的少突胶质细胞瘤进展为间变性少突胶质细胞瘤有关。

相似文献

1
Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.少突胶质细胞瘤的分子遗传学方面,包括通过比较基因组杂交进行分析。
Am J Pathol. 1999 Aug;155(2):375-86. doi: 10.1016/S0002-9440(10)65134-6.
2
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
3
Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.91例星形细胞瘤和少突胶质细胞瘤中1p、19q、10q、TP53、EGFR、CDK4和CDKN2A的组织学与分子遗传学分析的相关性
Clin Cancer Res. 2002 Jan;8(1):196-201.
4
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.少突胶质细胞瘤的分子异质性提示肿瘤进展存在替代途径。
Neurology. 2001 Oct 9;57(7):1278-81. doi: 10.1212/wnl.57.7.1278.
5
Molecular genetic alterations in glioblastomas with oligodendroglial component.具有少突胶质细胞成分的胶质母细胞瘤中的分子遗传学改变。
Acta Neuropathol. 2001 Apr;101(4):311-20. doi: 10.1007/s004010000258.
6
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.少突胶质细胞瘤和低级别弥漫性星形细胞瘤的表型与基因型相关性
Acta Neuropathol. 2002 Mar;103(3):267-75. doi: 10.1007/s004010100464. Epub 2001 Nov 22.
7
Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.少突胶质细胞瘤的分子遗传学分析显示,19号染色体长臂(19q)和1号染色体短臂(1p)存在优先等位基因缺失。
Am J Pathol. 1994 Nov;145(5):1175-90.
8
Molecular genetic evidence for subtypes of oligoastrocytomas.少突星形细胞瘤亚型的分子遗传学证据
J Neuropathol Exp Neurol. 1997 Oct;56(10):1098-104. doi: 10.1097/00005072-199710000-00003.
9
[Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].[1号和19号染色体杂合性缺失与胶质瘤中MGMT、p53和Ki-67蛋白表达的相关性]
Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):752-8.
10
[Loss of heterozygosity of chromosome 1p/19q and p53 protein expression in oligodendroglioma].[少突胶质细胞瘤中1p/19q染色体杂合性缺失与p53蛋白表达]
Zhonghua Bing Li Xue Za Zhi. 2009 Jul;38(7):445-50.

引用本文的文献

1
Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis.少突胶质细胞瘤中CDKN2A/B改变的频率及预后影响:系统评价与荟萃分析
Neurol Med Chir (Tokyo). 2024 Dec 15;64(12):442-450. doi: 10.2176/jns-nmc.2024-0105. Epub 2024 Oct 22.
2
Diffuse leptomeningeal glioneuronal tumor with distinct neuronal and glial components but identical diagnostic molecular and genetic features.弥漫性软脑膜神经胶质神经元肿瘤,具有明显的神经元和神经胶质成分,但具有相同的诊断分子和遗传特征。
Neuropathology. 2024 Dec;44(6):440-444. doi: 10.1111/neup.12996. Epub 2024 Jul 28.
3
Proteome-based insights for IDH-mutant glioma classification.基于蛋白质组学的 IDH 突变型脑胶质瘤分类研究。
Cell Rep Med. 2023 Jan 17;4(1):100909. doi: 10.1016/j.xcrm.2022.100909.
4
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
5
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.1p/19q 缺失检测在少突胶质细胞瘤诊断中的准确性:一项基于 Cochrane 系统评价的综合荟萃分析。
Neuropathol Appl Neurobiol. 2022 Jun;48(4):e12790. doi: 10.1111/nan.12790. Epub 2022 Mar 3.
6
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.CDKN2A 纯合缺失联合甲基化 MGMT 状态对 IDH 野生型胶质母细胞瘤的临床意义。
Cancer Med. 2021 May;10(10):3177-3187. doi: 10.1002/cam4.3860. Epub 2021 Apr 10.
7
Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas.成人弥漫性星形细胞瘤中FISH 1p/19q共缺失假阳性的频率。
Neurooncol Adv. 2020 Aug 27;2(1):vdaa109. doi: 10.1093/noajnl/vdaa109. eCollection 2020 Jan-Dec.
8
Microglia-Centered Combinatorial Strategies Against Glioblastoma.以小胶质细胞为中心的胶质母细胞瘤联合治疗策略。
Front Immunol. 2020 Sep 29;11:571951. doi: 10.3389/fimmu.2020.571951. eCollection 2020.
9
Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas.超越异柠檬酸脱氢酶(IDH)突变:成人弥漫性胶质瘤中新兴的分子诊断和预后特征
Cancers (Basel). 2020 Jul 6;12(7):1817. doi: 10.3390/cancers12071817.
10
Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification.根据2016年修订的世界卫生组织中枢神经系统肿瘤分类对蒙古弥漫性胶质瘤进行重新分类。
J Pathol Transl Med. 2019 Sep;53(5):298-307. doi: 10.4132/jptm.2019.07.15. Epub 2019 Aug 2.

本文引用的文献

1
Treatment of oligodendroglioma: an update.少突胶质细胞瘤的治疗:最新进展
Neuro Oncol. 1999 Jan;1(1):61-8.
2
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.间变性少突胶质细胞瘤患者化疗反应和生存的特定基因预测指标
J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9. doi: 10.1093/jnci/90.19.1473.
3
PTEN mutations in gliomas and glioneuronal tumors.胶质瘤和神经胶质神经元肿瘤中的PTEN突变
Oncogene. 1998 Apr 30;16(17):2259-64. doi: 10.1038/sj.onc.1201756.
4
Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas.少突胶质细胞瘤中杂合性缺失和微卫星不稳定性的筛查
Genes Chromosomes Cancer. 1998 Mar;21(3):207-16. doi: 10.1002/(sici)1098-2264(199803)21:3<207::aid-gcc4>3.3.co;2-7.
5
PTEN gene mutations are seen in high-grade but not in low-grade gliomas.PTEN基因突变见于高级别胶质瘤,而不见于低级别胶质瘤。
Cancer Res. 1997 Oct 1;57(19):4187-90.
6
Molecular genetic evidence for subtypes of oligoastrocytomas.少突星形细胞瘤亚型的分子遗传学证据
J Neuropathol Exp Neurol. 1997 Oct;56(10):1098-104. doi: 10.1097/00005072-199710000-00003.
7
Microsatellite analysis of childhood brain tumors.儿童脑肿瘤的微卫星分析
Genes Chromosomes Cancer. 1996 Jan;15(1):54-63. doi: 10.1002/(SICI)1098-2264(199601)15:1<54::AID-GCC8>3.0.CO;2-3.
8
Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization.通过比较基因组杂交对与胶质瘤进展相关的基因组改变进行表征。
Oncogene. 1996 Sep 5;13(5):983-94.
9
Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.人肉瘤中CDK4基因与MDM2和GLI的共扩增。
Cancer Res. 1993 Nov 15;53(22):5535-41.
10
Deletion mapping of chromosome 19 in human gliomas.人类胶质瘤中19号染色体的缺失图谱分析。
Int J Cancer. 1994 Jun 1;57(5):676-80. doi: 10.1002/ijc.2910570511.